Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Dexamethasone Dosing for Pain After TKA
NCT06339151Active, not recruiting
- Sponsor
- Thammasat University Hospital
- Start
- Mar 2022
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in postoperative pain (3 arms), sponsored by Thammasat University Hospital. Primary endpoint: Pain at rest and motion at 72 hours. Started Mar 2022; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06339151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339151.